Lantheus Holdings, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| LNTH | LQDA | I7G.F | UTHR | 2M7C.F | NBIX | |
|---|---|---|---|---|---|---|
| Market cap | 6.60B | 4.24B | 12.79B | 26.10B | 2.87B | 16.81B |
| P/E (TTM) | 24.5 | 34.1 | 25.1 | 23.0 | 14.8 | 24.6 |
| Forward P/E | 15.6 | 21.7 | — | 18.0 | — | 13.9 |
| Price/book | 5.0 | 21.6 | 2.7 | 3.7 | 1.2 | 4.3 |
| Dividend yield | — | — | 1.05% | — | 3.42% | — |
| 1-year change | +76.13% | +59.73% | +22.89% | +34.39% | −28.57% | +7.22% |
| Today | +0.34% | +12.27% | +2.04% | +1.19% | +2.61% | +0.73% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All LNTH news ›Comparing Lantheus (NASDAQ:LNTH) & Otsuka (OTCMKTS:OTSKY)
Posted by Danessa Lincoln on Nov 4th, 2026 Lantheus (NASDAQ:LNTH – Get Free Report) and Otsuka (OTCMKTS:OTSKY – Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the…
Lantheus Announces the FDA Approval of DEFINITY® (Perflutren Lipid Microsphere) for Pediatric Patients
“The expanded indication for DEFINITY is a testament to the rigorous research and development efforts undertaken by Lantheus to address unmet medical needs of pediatric patients,” said Jean-Claude Provost, MD, Chief Medical Officer. “We…
Lantheus receives FTC second request on Curium deal
Lantheus and Curium received an FTC second request on their $8B merger, extending review. Lantheus (LNTH) disclosed that it received a second request from the Federal Trade Commission regarding its $8 billion sale to Curium. Lantheus…
Lantheus Holdings, Inc. $LNTH Stake Lessened by Isthmus Partners LLC
Posted by Tristan Rich on Oct 23rd, 2026 Isthmus Partners LLC reduced its stake in Lantheus Holdings, Inc. (NASDAQ:LNTH – Free Report) by 75.3% in the third quarter, Holdings Channel.com reports. The institutional investor owned 10,737…
Banks jostle to join $4.25 billion debt backing Curium's Lantheus buyout
Briefs Finance helps everyday people get better with money and invest with confidence, from getting out of debt all the way to investing like an expert. It starts with Market Briefs, a free five-minute daily newsletter, and grows into…
Lantheus' shelved radioligand PNT2002 shows promise in earlier prostate cancer in UCLA trial
The LUNAR trial randomized 92 men with hormone-sensitive prostate cancer that had returned at one to five sites to stereotactic body radiotherapy (SBRT) alone or two cycles of 177Lu-PNT2002 followed by SBRT. Neither group received androgen…
JPMorgan Leads, Jefferies Joins $4.25 Billion Financing for Lantheus Deal
Published on 10/15/2026 at 08:59 am EDT The American consumer is resisting better than concerns about purchasing power suggest October 16, 2026 at 02:55 am EDT JPMorgan's Dimon Says Federal Debt May Lead to Bond Volatility, Higher Rates…
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Option Care Health, Inc. (Nasdaq – OPCH), Lantheus Holdings Inc. (Nasdaq – LNTH), MarketAxess Holdings Inc. (Nasdaq – MKTX), Sangoma Technologies Corporation (Nasdaq – SANG)
BALA CYNWYD, Pa., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ([email protected]) or Marc…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- themarketsdaily.com2
- briefs.co1
- daily-tribune.com1
- marketscreener.com1
- seekingalpha.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 6 articles, not a forecast.